145 related articles for article (PubMed ID: 15334310)
21. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
[TBL] [Abstract][Full Text] [Related]
24. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
Mroz RM; Holownia A; Chyczewska E; Braszko JJ
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of COPD.
Spurzem JR; Rennard SI
Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
27. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
28. Immunology of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells in asthma and COPD: opportunities for drug development.
Kool M; Lambrecht BN
Curr Opin Immunol; 2007 Dec; 19(6):701-10. PubMed ID: 17977704
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
Sadowska AM; Klebe B; Germonpré P; De Backer WA
Steroids; 2007 Jan; 72(1):1-6. PubMed ID: 17145070
[TBL] [Abstract][Full Text] [Related]
31. Prostanoids as pharmacological targets in COPD and asthma.
Rolin S; Masereel B; Dogné JM
Eur J Pharmacol; 2006 Mar; 533(1-3):89-100. PubMed ID: 16458293
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.
Rahman I
Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892
[TBL] [Abstract][Full Text] [Related]
33. Impact of protein acetylation in inflammatory lung diseases.
Ito K; Charron CE; Adcock IM
Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
[TBL] [Abstract][Full Text] [Related]
34. [Endogenous nitric oxide in obstructive pulmonary diseases].
Toczyska I; Chciałowski A; Lubiński W
Wiad Lek; 2005; 58(3-4):238-42. PubMed ID: 16119172
[TBL] [Abstract][Full Text] [Related]
35. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.
Stevenson CS; Birrell MA
Pharmacol Ther; 2011 May; 130(2):93-105. PubMed ID: 21074553
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics and condition of the bronchial tree in patients with bronchial asthma and chronic obstructive pulmonary disease in combination with hyperoxaluria].
Fedoseev GB; Petrova MA; Shaĭlieva LO; Kakliugin AP; Zorina ML; Sakharov AN; Pavliukova NO
Ter Arkh; 2007; 79(3):37-41. PubMed ID: 17526194
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
Szulakowski P; Mróz RM; Pierzchała W; Chyczewska E; MacNee W
Wiad Lek; 2006; 59(3-4):250-4. PubMed ID: 16813274
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease.
Hoffjan S; Stemmler S; Parwez Q; Petrasch-Parwez E; Arinir U; Rohde G; Reinitz-Rademacher K; Schultze-Werninghaus G; Bufe A; Epplen JT
BMC Med Genet; 2005 Sep; 6():34. PubMed ID: 16188043
[TBL] [Abstract][Full Text] [Related]
40. Alveolar macrophages as orchestrators of COPD.
Barnes PJ
COPD; 2004 Apr; 1(1):59-70. PubMed ID: 16997739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
